MASIMO CORP 4

4 · MASIMO CORP · Filed Mar 10, 2017

Insider Transaction Report

Form 4

Period: 2017-03-08

MASIMO CORPMASI

Jansen Paul

Executive VP, Marketing

Transactions

Exercise/Conversion
Common Stock
2017-03-08$30.06/sh+10,000$300,600→ 16,389 total
Exercise/Conversion
Common Stock
2017-03-10$19.90/sh+12,000$238,800→ 18,389 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-03-10$19.90/sh−12,000$238,800→ 8,000 total
Exercise: $19.90From: 2014-03-15Exp: 2023-03-15→ Common Stock (12,000 underlying)
Sale
Common Stock
2017-03-10$94.98/sh−12,000$1,139,760→ 6,389 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-03-08$30.06/sh−10,000$300,600→ 10,000 total
Exercise: $30.06From: 2012-02-22Exp: 2021-02-22→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2017-03-08$25.46/sh+3,611$91,936→ 10,000 total
Sale
Common Stock
2017-03-08$94.33/sh−3,611$340,635→ 6,389 total
Sale
Common Stock
2017-03-08$94.33/sh−10,000$943,315→ 6,389 total
Sale
Common Stock
2017-03-08$94.33/sh−10,000$943,300→ 6,389 total
Exercise/Conversion
Common Stock
2017-03-08$20.19/sh+20,000$403,800→ 26,389 total
Sale
Common Stock
2017-03-08$94.34/sh−20,000$1,886,730→ 6,389 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-03-08$25.46/sh−3,611$91,936→ 0 total
Exercise: $25.46From: 2009-04-17Exp: 2018-04-17→ Common Stock (3,611 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-03-08$20.19/sh−20,000$403,800→ 0 total
Exercise: $20.19From: 2012-10-27Exp: 2021-10-27→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock
2017-03-08$30.06/sh+10,000$300,600→ 16,389 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-03-08$30.06/sh−10,000$300,600→ 0 total
Exercise: $30.06From: 2012-02-22Exp: 2021-02-22→ Common Stock (10,000 underlying)

Footnotes (8)

[F1]The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of February 22, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
[F2]The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $94.12 per share to a high of $94.62 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $94.06 per share to a high of $94.69 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $94.03 per share to a high of $94.69 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F5]This option was granted on April 17, 2008 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
[F6]This option was granted on February 22, 2011 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
[F7]This option was granted on October 27, 2011 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
[F8]This option was granted on March 15, 2013 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.

Documents

1 file

4
wf-form4_148918522397445.xmlPrimary
FORM 4